Metrikler
Yayın
65
Açık Erişim
19
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (61)
SCI-E, SSCI, AHCI (55)
SCI-E, SSCI, AHCI, ESCI (59)
ESCI (4)
Scopus (54)
TRDizin (9)
2025
20251. Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitors
ŞAHİN T. K., AKSOY S., GÜVEN D. C.
EXPERT REVIEW OF ANTICANCER THERAPY
, sa.5, ss.471-484, 2025 (SCI-Expanded)
2025
20252. Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)
Majidova N., YASLIKAYA Ş., Mildanoglu M. M., COŞKUN A., ERCAN UZUNDAL D., ŞAHİN T. K., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.36, sa.5, ss.293-301, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
20253. Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer
Sahin T. K., Rizzo A., GÜVEN D. C., AKSOY S.
CANCER TREATMENT REVIEWS
, 2025 (SCI-Expanded, Scopus)
2025
20254. Fear of Cancer Recurrence and Associated Factors in Lymphoma Survivors and Their Family Caregivers: A Cross-Sectional Study
ŞAHİN T. K., Sahin E. A., Gungor H. N., GÜVEN D. C., BARIŞTA İ., AKIN S.
CANCER MEDICINE
, sa.7, 2025 (SCI-Expanded, Scopus)
2025
20255. Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors
BAŞ O., Tokatli M., Savkliyildiz M., Yazarkan Y., Guduk N., Kilinc C., et al.
EXPERT REVIEW OF ANTICANCER THERAPY
, sa.4, ss.405-409, 2025 (SCI-Expanded)
2025
20256. The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors
ŞAHİN T. K., GÜVEN D. C., Durukan M., KAVGACI G., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
, sa.4, ss.129-137, 2025 (SCI-Expanded)
2025
20257. The role of the microbiome in head and neck squamous cell cancers
ŞAHİN T. K., SÖNMEZER M. Ç.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
, sa.2, ss.623-637, 2025 (SCI-Expanded, Scopus)
2025
20258. The perspectives and knowledge of patients with cancer on mpox and mpox vaccination: a cross-sectional study
ŞAHİN T. K., KAYGUSUZ Y., Icli M. C., AKSOY S., GÜVEN D. C.
CURRENT MEDICAL RESEARCH AND OPINION
, sa.1, ss.83-91, 2025 (SCI-Expanded, Scopus)
2025
20259. The association between HALP score and survival in patients treated with immune checkpoint inhibitors
ŞAHİN T. K., GÜVEN D. C., Durukan M., BAŞ O., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF ANTICANCER THERAPY
, sa.1, ss.81-89, 2025 (SCI-Expanded)
2024
202410. Post-operative serum CEA predicts prognosis in HR-positive/HER2-negative early breast cancer
KAVGACI G., ŞAHİN T. K., Muderrisoglu T., Ileri S., GÜVEN D. C., AKSOY S.
EXPERT REVIEW OF ANTICANCER THERAPY
, sa.12, ss.1319-1326, 2024 (SCI-Expanded)
2024
202411. Ribociclib-induced autoimmune-like hepatitis: a case report
KAVGACI G., ŞAHİN T. K., SÖKMENSÜER C., BALABAN H. Y., AKSOY S.
JOURNAL OF CHEMOTHERAPY
, 2024 (SCI-Expanded, Scopus)
2024
202412. Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis
ŞAHİN T. K., Ayasun R., Rizzo A., Guven D. C.
CANCERS
, cilt.16, sa.21, 2024 (SCI-Expanded, Scopus)
2024
202413. Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis
Sahin T. K., Guven D. C.
CLINICAL NUTRITION ESPEN
, cilt.63, ss.829-836, 2024 (ESCI, Scopus)
2024
202414. Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine
ŞAHİN T. K., AKYILDIZ A., DOĞAN O. T., KAVGACI G., GÜVEN D. C., AKSOY S.
PHARMACEUTICALS
, cilt.17, sa.7, 2024 (SCI-Expanded, Scopus)
2024
202415. Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis
Sahin T. K., Rizzo A., AKSOY S., Guven D. C.
CANCERS
, cilt.16, sa.10, 2024 (SCI-Expanded, Scopus)
2024
202416. The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis
Guven D. C., Sahin T. K.
Breast Cancer Research and Treatment
, cilt.204, sa.3, ss.443-452, 2024 (SCI-Expanded, Scopus)
2024
202417. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
Sahin T. K., ÖZBAY Y., ALTUNBULAK A. Y., ALTUNBULAK H. İ., ONUR M. R., Ceylan F., et al.
International Journal of Clinical Oncology
, 2024 (SCI-Expanded, Scopus)
2024
202418. Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
GÜVEN D. C., Stephen B., ŞAHİN T. K., ÇAKIR İ. Y., AKSOY S.
Laryngoscope
, cilt.134, sa.1, ss.7-17, 2024 (SCI-Expanded, Scopus)
2023
202319. Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosis
ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., METAN G., SARIBAŞ Z., et al.
Heliyon
, cilt.9, sa.11, 2023 (SCI-Expanded, Scopus)
2023
202320. The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study
GÜVEN D. C., Yekeduz E., Erul E., YAZGAN S. C., ŞAHİN T. K., KARATAŞ G., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
, cilt.149, sa.7, ss.3599-3606, 2023 (SCI-Expanded, Scopus)
2023
202321. The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors
GÜVEN D. C., ÖZBEK D. A., ŞAHİN T. K., KAVGACI G., Aksun M. S., ERUL E., et al.
Anti-Cancer Drugs
, cilt.34, sa.6, ss.783-790, 2023 (SCI-Expanded, Scopus)
2023
202322. Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy
ŞAHİN T. K., Bilir B., Kucuk O.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
, cilt.63, sa.15, ss.2494-2508, 2023 (SCI-Expanded, Scopus)
2023
202323. Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data
Sütcüoğlu O., Doğan A., Yilmaz F., Şahin A. B., ŞAHİN T. K., Esen S. A., et al.
Pancreas
, cilt.52, sa.4, 2023 (SCI-Expanded, Scopus)
2023
202324. Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer
Ceylan F., Guven D. C., Taban H., Aktepe O., ŞAHİN T. K., Kilickap S., et al.
Clinics and Research in Hepatology and Gastroenterology
, cilt.47, sa.3, 2023 (SCI-Expanded, Scopus)
2023
202325. Knowledge and Attitudes of Turkish Physicians towards Human Monkeypox Disease and Related Vaccination: A Cross-Sectional Study
ŞAHİN T. K., ERUL E., AKSUN M. S., SÖNMEZER M. Ç., ÜNAL S., AKOVA M.
Vaccines
, cilt.11, sa.1, 2023 (SCI-Expanded, Scopus)
2022
202226. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
GÜVEN D. C., ŞAHİN T. K., ERUL E., Rizzo A., Ricci A. D., AKSOY S., et al.
Frontiers in Molecular Biosciences
, cilt.9, 2022 (SCI-Expanded, Scopus)
2022
202227. The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges
GÜVEN D. C., ŞAHİN T. K., Rizzo A., Ricci A. D., AKSOY S., ŞAHİN K.
APPLIED SCIENCES-BASEL
, cilt.12, sa.20, 2022 (SCI-Expanded, Scopus)
2022
202228. Independent predictors of in-hospital mortality and the need for intensive care in hospitalized non-critical COVID-19 patients: a prospective cohort study
ÇALIK BAŞARAN N., ÖZDEDE M., UYAROĞLU O. A., ŞAHİN T. K., ÖZCAN B., ORAL H., et al.
INTERNAL AND EMERGENCY MEDICINE
, cilt.17, sa.5, ss.1413-1424, 2022 (SCI-Expanded, Scopus)
2022
202229. The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy
GÜVEN D. C., ŞAHİN T. K., Erul E., ÇAKIR İ. Y., ÜÇGÜL E., YILDIRIM H. Ç., et al.
JOURNAL OF CLINICAL MEDICINE
, cilt.11, sa.15, 2022 (SCI-Expanded, Scopus)
2022
202230. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic
ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., HALAÇLI B., DURHAN G., et al.
MYCOSES
, cilt.65, ss.724-732, 2022 (SCI-Expanded, Scopus)
2022
202231. Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey
SÖNMEZER M. Ç., TELLİ DİZMAN G., Erul E., ŞAHİN T. K., SARICAOĞLU T., Alp A., et al.
VACCINES
, cilt.10, sa.7, 2022 (SCI-Expanded, Scopus)
2022
202232. The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis
GÜVEN D. C., ŞAHİN T. K., Erul E., KILIÇKAP S., Gambichler T., AKSOY S.
CANCERS
, cilt.14, sa.11, 2022 (SCI-Expanded, Scopus)
2022
202233. The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy
GÜVEN D. C., KAVGACI G., AKTEPE O. H., YILDIRIM H. H., ŞAHİN T. K., AKSOY S., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.28, sa.4, ss.785-793, 2022 (SCI-Expanded, Scopus)
2022
202234. The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials
GÜVEN D. C., Stephen B., ŞAHİN T. K., ÇAKIR İ. Y., Erul E., AKSOY S.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
, cilt.174, 2022 (SCI-Expanded, Scopus)
2022
202235. Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey
SÖNMEZER M. Ç., Erul E., ŞAHİN T. K., Rudvan Al I., Cosgun Y., Korukluoglu G., et al.
VACCINES
, cilt.10, sa.2, 2022 (SCI-Expanded, Scopus)
2022
202236. Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey
SÖNMEZER M. Ç., ŞAHİN T. K., Erul E., Ceylan F. S., Hamurcu M. Y., Morova N., et al.
VACCINES
, cilt.10, sa.2, 2022 (SCI-Expanded, Scopus)
2022
202237. Hyperlipidemia in Post-COVID patients; a unique observational follow-up study on lipid levels in post-COVID patients
UYAROĞLU O. A., ÖZDEDE M., ÇALIK BAŞARAN N., KÖYLÜ B., ŞAHİN T. K., ÖZIŞIK L., et al.
JOURNAL OF HEALTH SCIENCES AND MEDICINE
, cilt.5, sa.1, ss.220-226, 2022 (TRDizin)
2022
202238. The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study
GÜVEN D. C., YILDIRIM H. Ç., ERUL E., ŞAHİN T. K., ÇAKIR İ. Y., AKTEPE O. H., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.5, ss.1551-1558, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202139. Correlation Between THSD7A Expression and Tumor Characteristics of Azoxymethane-Induced Colon Cancer Model in Rats
AKTEPE O. H., ŞAHİN T. K., GÜNER G., GÜVEN D. C., YETER H. H., KURTULAN O., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.32, sa.12, ss.1049-1056, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202140. A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer
GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., AKTEPE O. H., DİZDAR Ö., YALÇIN Ş.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
, cilt.168, 2021 (SCI-Expanded, Scopus)
2021
202141. Evaluation of Corrected QT Intervals of 74 COVID19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or Favipiravir
UYAROĞLU O. A., ŞENER Y. Z., ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., ŞAHİN T. K., et al.
European Journal of Therapeutics
, cilt.27, sa.4, ss.311-317, 2021 (ESCI, TRDizin)
2021
202142. The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy
AKTEPE O. H., GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇELİKTEN B., Yeter H. H., et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
, cilt.73, sa.10, ss.1957-1963, 2021 (SCI-Expanded, Scopus)
2021
202143. Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review
GÜVEN D. C., ŞAHİN T. K., KILIÇKAP S., Uckun F. M.
FRONTIERS IN ONCOLOGY
, cilt.11, 2021 (SCI-Expanded, Scopus)
2021
202144. Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality
GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇEŞMECİ E., Incesu F. G. G., TAHILLIOĞLU Y., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE
, 2021 (SCI-Expanded, Scopus)
2021
202145. Clinical Outcomes and Independent Risk Factors for 90-Day Mortality in Critically Ill Patients with Respiratory Failure Infected with SARS-CoV-2: A Multicenter Study in Turkish Intensive Care Units
GÜNDOĞAN K., AKBUDAK İ. H., Hanci P., HALAÇLI B., TEMEL Ş., Gullu Z., et al.
BALKAN MEDICAL JOURNAL
, cilt.38, sa.5, ss.296-305, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202146. Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy
GÜVEN D. C., AKSUN M. S., ŞAHİN T. K., AKTEPE O. H., YILDIRIM H. Ç., TABAN H., et al.
SUPPORTIVE CARE IN CANCER
, cilt.29, sa.9, ss.5417-5423, 2021 (SCI-Expanded, Scopus)
2021
202147. Lower prognostic nutritional index is associated with poorer survival in patients receiving immune-checkpoint inhibitors
GÜVEN D. C., AKTEPE O. H., TABAN H., AKTAŞ B. Y., GÜNER G., YILDIRIM H. H., et al.
BIOMARKERS IN MEDICINE
, cilt.15, sa.13, ss.1123-1130, 2021 (SCI-Expanded, Scopus)
2021
202148. THE INCIDENCE AND RISK FACTORS FOR ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A REAL-LIFE STUDY
GÜVEN D. C., ÖZBEK D. A., ŞAHİN T. K., AKSUN M. S., KAVGACI G., Cebrayilov C., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION
, cilt.36, 2021 (SCI-Expanded, Scopus)
2021
202149. Artificial intelligence method to predict overall survival of hepatocellular carcinoma
ŞİMŞEK C., GÜVEN D. C., Sahin T. K., TEKİN İ. E., Sahan O., BALABAN H. Y., et al.
Hepatology Forum
, cilt.2, sa.2, ss.64-68, 2021 (Scopus)
2021
202150. Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors
GÜVEN D. C., ŞAHİN T. K., AKSUN M. S., TABAN H., AKTEPE O. H., METİN AKSU N., et al.
SUPPORTIVE CARE IN CANCER
, cilt.29, sa.4, ss.2029-2035, 2021 (SCI-Expanded, Scopus)
2021
202151. Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma
AKTEPE O. H., GÜNER G., GÜVEN D. C., TABAN H., YILDIRIM H. Ç., ŞAHİN T. K., et al.
TURKISH JOURNAL OF UROLOGY
, cilt.47, sa.2, ss.113-119, 2021 (ESCI, Scopus, TRDizin)
2021
202152. Thyroid gland metastasis mimicking thyroid carcinoma in a lung cancer patient and dramatic response to crizotinib: A case report
Erul E., GÜVEN D. C., ŞAHİN T. K., Gullu İ. H.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.69, sa.1, ss.98-101, 2021 (ESCI, Scopus, TRDizin)
2021
202153. Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients
İNKAYA A. Ç., KARA E., ÇALIK BAŞARAN N., ŞAHİN T. K., UYAROĞLU O. A., UZUN Ö., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.5, ss.2786-2788, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202054. The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters
GÜVEN D. C., ŞAHİN T. K., AKSOY S.
BREAST JOURNAL
, cilt.26, sa.12, ss.2435-2436, 2020 (SCI-Expanded, Scopus)
2020
202055. Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives
C Guven D., ŞAHİN T. K., DİZDAR Ö., KILIÇKAP S.
BIOMARKERS IN MEDICINE
, cilt.14, ss.1383-1392, 2020 (SCI-Expanded, Scopus)
2020
202056. All Positives May Not Be the Same in Pancreatic Cancer Lessons Learned From the Past
Ceylan F., GÜVEN D. C., ŞAHİN T. K., ÖZBEK D. A., DİZDAR Ö.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.43, sa.9, ss.676, 2020 (SCI-Expanded, Scopus)
2020
202057. Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19
GÜVEN D. C., ŞAHİN T. K., AKTEPE O. H., YILDIRIM H. Ç., AKSOY S., KILIÇKAP S.
FRONTIERS IN ONCOLOGY
, cilt.10, 2020 (SCI-Expanded, Scopus)
2020
202058. Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61
ŞAHİN T. K., AKTEPE O. H., Uckun F. M., YALÇIN Ş.
ANTI-CANCER DRUGS
, cilt.31, sa.6, ss.609-616, 2020 (SCI-Expanded, Scopus)
2020
202059. Spontaneous subepithelial hemorrhage of renal pelvis and ureter (Antopol-Goldman lesion) in hemophilia A patient with inhibitor Case report and review of the literature
ŞAHİN T. K., ALADAĞ KARAKULAK E., Setterzade E., SAİN GÜVEN G., HAZNEDAROĞLU İ. C., AKSU S.
MEDICINE
, cilt.99, sa.26, 2020 (SCI-Expanded, Scopus)
2020
202060. Prevention of DMBA-induced mammary gland tumors in mice by a dual-function inhibitor of JAK3 and EGF receptor tyrosine kinases
ŞAHİN K., YABAŞ M., ORHAN C., TUZCU M., ŞAHİN T. K., ÖZERCAN İ. H., et al.
EXPERT OPINION ON THERAPEUTIC TARGETS
, cilt.24, sa.4, ss.379-387, 2020 (SCI-Expanded, Scopus)
2020
202061. Chemopreventive efficacy of stampidine in a murine breast cancer model
ŞAHİN K., ORHAN C., ÖZERCAN İ. H., TUZCU M., ELİBOL B., ŞAHİN T. K., et al.
EXPERT OPINION ON THERAPEUTIC TARGETS
, cilt.24, sa.2, ss.155-162, 2020 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2021
20211. SURVEILLANCE FOR INVASIVE PULMONARY ASPERGILLOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19
ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., HALAÇLI B., DURHAN G., et al.
18. ULUSAL DAHİLİ VE CERRAHİ BİLİMLER YOĞUN BAKIM E-KONGRESİ VE 10. AVRASYA YOĞUN BAKIM E-TOPLANTISI, Ankara, Türkiye, 6 - 09 Aralık 2021, cilt.12, (Özet Bildiri)
2018
20182. ANKARA’DA BAZI AKARYAKIT İSTASYONLARINDA ÇALIŞANLARIN İSTASYONDA OLASI BİR YANGIN/PATLAMA ÖNCESİ/SIRASI/SONRASINDA YAPILACAKLAR KONUSUNDA BAZI BİLGİ VE GÖRÜŞLERİ
ERCAN T. M. F., Çakır İ. Y., ŞAHİN T. K., Ayhan B., Bulut R., GÜLBAHÇE F. G., et al.
2.Uluslararası - 20.Ulusal Halk Sağlığı Kongresi, 13 - 17 Kasım 2018, (Özet Bildiri)
2015
20153. THE EFFECTS OF BMI ON RESPIRATORY AND HEMODYNAMIC PARAMETERS IN LAPAROSCOPIC BARIATRIC SURGERY: AN OBSERVATIONAL STUDY
Ayyildiz A., PAMUK A. G., ÜZÜMCÜGİL F., AKÇA B., Yilbas A. A., ŞAHİN T. K., et al.
20th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), Vienna, Avusturya, 26 - 29 Ağustos 2015, cilt.25, (Özet Bildiri)
2009
20094. Mineralogical and geochemical characteristics of the borate bearing Kirka volcanosedimentary lacustrine basin, Gocenoluk Area, Eskisehir, Western Anatolia, Turkey: Preliminary results
ŞAHİN T. K., TEMEL A., Sylvester P.
19th Annual VM Goldschmidt Conference, Davos, İsviçre, 21 Haziran 2009, cilt.73, (Özet Bildiri)